Consistent with this protumorigenic role, the high mRNA level of PHLDB3 is correlated with worse prognosis of gastric cancer patients, as well as less TP53 mutations (Supplementary Fig. 1; Fig. 3c,d). Here, TP53 is linked to gastric cancer.